Skip Header

You are using a version of browser that may not display all the features of this website. Please consider upgrading your browser.
1 to 10 of 10  Show

Literature citations Results

Novel carbazole inhibits phospho-STAT3 through induction of protein-tyrosine phosphatase PTPN6.

Hou S., Yi Y.W., Kang H.J., Zhang L., Kim H.J., Kong Y., Liu Y., Wang K., Kong H.S., Grindrod S. et al.

J. Med. Chem. 57:6342-6353(2014) · Mapped (1)

Inhibition of RPTOR overcomes resistance to EGFR inhibition in triple-negative breast cancer cells.

You K.S., Yi Y.W., Kwak S.J., Seong Y.S.

Int. J. Oncol. 52:828-840(2018) · Mapped (4)

Inhibition of NRF2 by PIK-75 augments sensitivity of pancreatic cancer cells to gemcitabine.

Duong H.Q., Yi Y.W., Kang H.J., Hong Y.B., Tang W., Wang A., Seong Y.S., Bae I.

Int. J. Oncol. 44:959-969(2014) · Mapped (5)

Inhibition of constitutively activated phosphoinositide 3-kinase/AKT pathway enhances antitumor activity of chemotherapeutic agents in breast cancer susceptibility gene 1-defective breast cancer cells.

Yi Y.W., Kang H.J., Kim H.J., Hwang J.S., Wang A., Bae I.

Mol. Carcinog. 52:667-675(2013) · Mapped (19)

Inhibition of checkpoint kinase 2 (CHK2) enhances sensitivity of pancreatic adenocarcinoma cells to gemcitabine.

Duong H.Q., Hong Y.B., Kim J.S., Lee H.S., Yi Y.W., Kim Y.J., Wang A., Zhao W., Cho C.H., Seong Y.S. et al.

J. Cell. Mol. Med. 17:1261-1270(2013) · Mapped (1)

Increased expression of cyclin G1 in leiomyoma compared with normal myometrium.

Baek W.K., Kim D., Jung N., Yi Y.W., Kim J.M., Cha S.D., Bae I., Cho C.H.

Am. J. Obstet. Gynecol. 188:634-639(2003) · Mapped (5)

HER2 confers drug resistance of human breast cancer cells through activation of NRF2 by direct interaction.

Kang H.J., Yi Y.W., Hong Y.B., Kim H.J., Jang Y.J., Seong Y.S., Bae I.

Sci Rep 4:7201-7201(2014) · Mapped (18)

CR6-interacting factor 1 interacts with Gadd45 family proteins and modulates the cell cycle.

Chung H.K., Yi Y.-W., Jung N.-C., Kim D., Suh J.M., Kim H., Park K.C., Song J.H., Kim D.W., Hwang E.S. et al.

J. Biol. Chem. 278:28079-28088(2003) · UniProtKB (4) · Mapped (7)

BRCA1 negatively regulates IGF-1 expression through an estrogen-responsive element-like site.

Kang H.J., Yi Y.W., Kim H.J., Hong Y.B., Seong Y.S., Bae I.

Cell Death Dis 3:e336-e336(2012) · Mapped (7)

beta-TrCP1 degradation is a novel action mechanism of PI3K/mTOR inhibitors in triple-negative breast cancer cells.

Yi Y.W., Kang H.J., Bae E.J., Oh S., Seong Y.S., Bae I.

Exp. Mol. Med. 47:e143-e143(2015) · Mapped (1)

1 to 10 of 10  Show
UniProt is an ELIXIR core data resource
Main funding by: National Institutes of Health

We'd like to inform you that we have updated our Privacy Notice to comply with Europe’s new General Data Protection Regulation (GDPR) that applies since 25 May 2018.

Do not show this banner again